Endexx’s Client Etain Wins Coveted Medical Marijuana License in New York

Endexx Corporation (OTC PINK: EDXC) is pleased to announce that GreenLeaf Consulting, a wholly owned subsidiary of Endexx, providing focused consulting services for medical marijuana license applicants and industry participants, led a successful bid for Etain, a women owned enterprise in the state of New York. Etain is one of the five organizations from forty three applicants that were granted a license to grow and dispense medical marijuana in the state of New York.

Joseph Stevens, Founder and President of GreenLeaf Consulting stated: “I am proud of Etain. They are a strong team of women motivated by and dedicated to serving the best interests of the patients of New York. Working with Etain to date has been rewarding and I look forward to continuing to support them through the next phases as they ready the operation to serve New York in January 2016.” Mr. Stevens has been working diligently with Etain over the past year. Mr. Steven’s collaboration efforts, based on high integrity and depth of expertise, helped navigate the politically charged and complex processes involved. Mr. Steven’s ability to identify and address the critical requirements and pitfalls in the application process resulted in creating a positive outcome.

Todd Davis, CEO of Endexx, “Etain has earned the opportunity to be a leader in the Medical Marijuana business in New York. They have a tremendous challenge ahead for the next six months as they prepare to launch their business. The Etain team is a strong and cohesive group that is especially suited for this endeavor. Endexx will fully support Greenleaf and Etain and look to further collaborate to execute the build out of their growing and dispensing operations.”

GreenLeaf Consulting provides consulting and advisory services to industry participants in several states to assist with application preparation and securing licensing. Services include business development, licensing approval, compliance, location assessment, facility design, security, equipment technology, plant management, harvesting, processing and packaging protocols. In addition GreenLeaf Consulting assists clients in formulating a strategic expansion plan that includes identification of opportunities and the development of winning strategies.

Etain is a woman owned organization that is run by Amy, Hillary and Keeley Peckham. Etain is already making plans to renovate a 12,000 square feet barn in Chester, New York for cultivation and will operate four dispensaries in the state. Licensees only have six months to open dispensaries and start operations.

About Endexx

Endexx provides innovative medical marijuana management and technology solutions. Endexx with its collaboration partners and consultants develops and distributes two consumable product lines derived from industrial hemp that is organic and naturally rich in phytocannabinoids. The company has two technology products and services that launched in 2014 — the M3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana to maintain compliance with the laws of National and State governments, and local regulatory bodies, as well as provide a smooth transition to the eventual Federal mandates. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers. Websites are www.cbdhealthsolutions.com, www.cbdunlimited.com, www.endexx.com, www.m3hub.com.

Safe Harbor Notice

This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

For further investor and media information, contact:
Endexx Corporation
Todd Davis
Chairman & CEO

IRTH Communications
Robert Haag
Managing Director

Comments are closed.

Get the latest content first.
©Marijuana Stocks Report